Meropenem for injection

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial PneumoniaMental Health Issue

Phase 2

Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria

RecruitingNCT07512596

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

Start: 2026-07-21End: 2027-07-01Target: 48Updated: 2026-09-04

Phase 3

A Clinical Trial for the Treatment of Carbapenem Resistant Gram-negative Bacterial Infection With Colistimethate Sodium for Injection

RecruitingNCT06198764

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Mental Health Issue

Start: 2023-07-06End: 2026-03-31Target: 80Updated: 2024-01-10